Drug profile · INN
phenmetrazine hydrochloride
PRELUDIN
phenmetrazine hydrochloride (PRELUDIN) is a dopamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — phenmetrazine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
phenmetrazine hydrochloride (PRELUDIN) is a dopamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is phenmetrazine hydrochloride?
phenmetrazine hydrochloride (PRELUDIN) is a dopamine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for phenmetrazine hydrochloride?
PRELUDIN is a marketed brand name for phenmetrazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phenmetrazine hydrochloride?
phenmetrazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.